These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11678958)

  • 1. Effective oral administration of tacrolimus in renal transplant recipients.
    Kimikawa M; Kamoya K; Toma H; Teraoka S
    Clin Transplant; 2001 Oct; 15(5):324-9. PubMed ID: 11678958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
    Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
    Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z; Dashti-Khavidaki S; Nasiri-Toosi M; Khalili H; Jafarian A; Irajian H; Abdollahi A; Sadrai S
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients.
    Stifft F; Undre N; van Hooff JP; Christiaans MH
    Ther Drug Monit; 2016 Aug; 38(4):456-62. PubMed ID: 27128604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients.
    Tanzi MG; Undre N; Keirns J; Fitzsimmons WE; Brown M; First MR
    Clin Transplant; 2016 Aug; 30(8):901-11. PubMed ID: 27220013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual administration improves systemic exposure of tacrolimus in kidney transplant recipients: comparison with oral administration.
    Federico S; Carrano R; Sabbatini M; Nappi R; Russo L; Apicella L; Balletta MM; Santangelo M; Mosca T; Tarantino G; Capone D
    Eur J Clin Invest; 2016 Jul; 46(7):651-7. PubMed ID: 27240092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
    Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronopharmacokinetics of tacrolimus in kidney transplant recipients: occurrence of acute rejection.
    Tada H; Satoh S; Iinuma M; Shimoda N; Murakami M; Hayase Y; Kato T; Suzuki T
    J Clin Pharmacol; 2003 Aug; 43(8):859-65. PubMed ID: 12953343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tacrolimus in pediatric renal transplant recipients.
    Shishido S; Asanuma H; Tajima E; Honda M; Nakai H
    Transplant Proc; 2001; 33(1-2):1066-8. PubMed ID: 11267193
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants.
    Undre N; Dickinson J
    BMJ Open; 2017 Apr; 7(4):e012252. PubMed ID: 28377389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.
    Wallemacq PE; Furlan V; Möller A; Schäfer A; Stadler P; Firdaous I; Taburet AM; Reding R; Clement De Clety S; De Ville De Goyet J; Sokal E; Lykavieris L; Van Leeuw V; Bernard O; Otte JB; Undre NA
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):367-70. PubMed ID: 9842978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients.
    Christiaans M; van Duijnhoven E; Beysens T; Undre N; Schäfer A; van Hooff J
    Transplant Proc; 1998 Jun; 30(4):1271-3. PubMed ID: 9636516
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study.
    Solari S; Cancino A; Wolff R; Norero B; Vargas JI; Barrera F; Guerra JF; Martínez J; Jarufe N; Soza A; Arrese M; Benitez C
    Aliment Pharmacol Ther; 2017 May; 45(9):1225-1231. PubMed ID: 28261844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.